147 related articles for article (PubMed ID: 30920650)
1. Single-agent taxane is useful in palliative chemotherapy for advanced extramammary Paget disease: a case series.
Kato M; Yoshino K; Maeda T; Nagai K; Oaku S; Hiura A; Fujisawa Y
Br J Dermatol; 2019 Oct; 181(4):831-832. PubMed ID: 30920650
[No Abstract] [Full Text] [Related]
2. Weekly docetaxel monotherapy for metastatic extramammary Paget's disease: Retrospective single-institute analysis.
Nakamura Y; Tanese K; Hirai I; Fukuda K; Kawakami Y; Amagai M; Funakoshi T
J Dermatol; 2020 Apr; 47(4):418-422. PubMed ID: 32020662
[TBL] [Abstract][Full Text] [Related]
3. Monitoring serum cytokeratin 19 fragment 21-1 to determine the efficacy of docetaxel chemotherapy in advanced extramammary Paget's disease.
Onishi M; Maeda F; Akasaka T; Amano H
J Dermatol; 2019 Mar; 46(3):e83-e84. PubMed ID: 30194782
[No Abstract] [Full Text] [Related]
4. S-1 in combination with docetaxel as salvage therapy for patients with metastatic extramammary Paget's disease.
Fukuda K; Hirai I; Nakamura Y; Fusumae T; Tanese K; Yaguchi T; Kawakami Y; Funakoshi T
Eur J Dermatol; 2020 Jun; 30(3):301-302. PubMed ID: 32540820
[No Abstract] [Full Text] [Related]
5. Case of metastatic extramammary Paget's disease treated with trastuzumab-biosimilar monotherapy after S-1 and docetaxel combination chemotherapy.
Kimura T; Akamatsu Y; Kajihara I; Fukushima S; Ihn H
J Dermatol; 2020 Jan; 47(1):e1-e2. PubMed ID: 31571250
[No Abstract] [Full Text] [Related]
6. Conservative management of extramammary paget disease with imiquimod.
Baiocchi G; Begnami MD; Fukazawa EM; Surima WS; Badiglian-Filho L; Costa FD; Oliveira RA; Faloppa CC; Kumagai LY; Soares FA
J Low Genit Tract Dis; 2012 Jan; 16(1):59-63. PubMed ID: 21964211
[TBL] [Abstract][Full Text] [Related]
7. Treatment of limited extent extramammary Paget's disease with 5 percent imiquimod cream.
Badgwell C; Rosen T
Dermatol Online J; 2006 Jan; 12(1):22. PubMed ID: 16638390
[TBL] [Abstract][Full Text] [Related]
8. Successful TS-1 monotherapy as the second-line treatment for advanced extramammary Paget's disease: A report of two cases.
Kato J; Hida T; Yamashita T; Kamiya S; Horimoto K; Sato S; Takahashi H; Sawada M; Yamada M; Uhara H
J Dermatol; 2018 Jan; 45(1):80-82. PubMed ID: 28891079
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel Combined With Cisplatin for Metastatic Extramammary Paget Disease.
Cai H; Xu W; Yu B; Li X; Zhu L; Xu Z; Zhou J; Zheng Y; Zou Q; Zeng Y; Wang X; Xu T
Clin Genitourin Cancer; 2018 Aug; 16(4):e899-e901. PubMed ID: 29685612
[TBL] [Abstract][Full Text] [Related]
10. Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease.
Molina GE; Khalifian S; Mull JL; Chen L; Rosman IS; Faulkner-Jones BE; Ngo KH; Demehri S; Cornelius LA; Wu PA
JAMA Dermatol; 2019 May; 155(5):599-603. PubMed ID: 30785593
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of low-dose 5-fluorouracil/cisplatin therapy for invasive extramammary Paget's disease.
Kato H; Watanabe S; Kariya K; Nakamura M; Morita A
J Dermatol; 2018 May; 45(5):560-563. PubMed ID: 29446148
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Matsushita S; Yonekura K; Mera K; Kawai K; Kanekura T
J Dermatol; 2011 Oct; 38(10):996-8. PubMed ID: 21972953
[No Abstract] [Full Text] [Related]
13. Exploratory Assessment of Oxygen Flow-Assisted Cutaneous Administration of Methotrexate for Superficial Basal Cell Carcinoma, Mycosis Fungoides, and Extramammary Paget Disease.
Lebas E; Chapelier C; Quatresooz P; Seidel L; Nikkels AF
J Invest Dermatol; 2020 Mar; 140(3):583-592. PubMed ID: 31513804
[TBL] [Abstract][Full Text] [Related]
14. Perineal extramammary Paget disease responsive to topical imiquimod.
Cecchi R; Pavesi M; Bartoli L; Brunetti L; Rapicano V
J Dtsch Dermatol Ges; 2010 Jan; 8(1):38-40. PubMed ID: 20096058
[TBL] [Abstract][Full Text] [Related]
15. Sequential use with imiquimod and surgery in extramammary Paget's disease.
Toledo F; Silvestre JF; Cuesta L; Ballester I; Latorre N; Monteagudo A
Dermatol Ther; 2012; 25(1):82-5. PubMed ID: 22591501
[TBL] [Abstract][Full Text] [Related]
16. Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease.
Sawada M; Kato J; Yamashita T; Yoneta A; Hida T; Horimoto K; Sato S; Uhara H
J Dermatol; 2018 Feb; 45(2):216-219. PubMed ID: 29115681
[TBL] [Abstract][Full Text] [Related]
17. Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens.
Koizumi S; Doi R; Aitake U; Lei X; Izumi T; Mori T; Shojiguchi N; Kawasaki T; Inozume T; Kishi A
J Dermatol; 2024 Jun; 51(6):e203-e204. PubMed ID: 38216840
[No Abstract] [Full Text] [Related]
18. Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review.
Cohen PR; Schulze KE; Tschen JA; Hetherington GW; Nelson BR
South Med J; 2006 Apr; 99(4):396-402. PubMed ID: 16634252
[TBL] [Abstract][Full Text] [Related]
19. Extramammary Paget disease: failure to respond to topical imiquimod 5%.
Jim On SC; Izumi AK
J Am Acad Dermatol; 2011 Sep; 65(3):656-657. PubMed ID: 21839324
[No Abstract] [Full Text] [Related]
20. Treatment of extramammary Paget disease of the vulva with imiquimod: a retrospective, multicenter study by the German Colposcopy Network.
Luyten A; Sörgel P; Clad A; Gieseking F; Maass-Poppenhusen K; Lellé RJ; Harter P; Buttmann N; Petry KU
J Am Acad Dermatol; 2014 Apr; 70(4):644-650. PubMed ID: 24433876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
